Hudson Technologies announced on September 17 that it signed a joint development agreement with Icorium to commercialize patented extractive distillation technology, gaining access to separation intellectual property, dedicated engineering resources, and exclusivity during initial commercialization. The goal is to recover more usable refrigerant from complex mixtures. The company has a clear reason to pursue better processing economics: second-quarter revenue rose 8% year over year to $78.3 million, but gross margin fell to 26% from 31%, and net income dropped to $4.9 million from $10.2 million a year earlier as selling prices declined 6%. Hudson reported $128.1 million of inventory as of June 30, though the portion suitable for the new process remains undisclosed. The announcement provided no quantified recovery yields, throughput, processing cost per pound, project budget, commercial launch date, or financial terms, and the agreement establishes no quantified earnings contribution. Insider Monkey's database showed 19 hedge funds holding Hudson Technologies at the end of 2Q2026, down from 21 funds three months earlier.
Hudson Technologies IncHudson signed a joint development agreement with Icorium to commercialize patented extractive distillation technology, gaining separation IP and exclusivity to recover more usable refrigerant.
OK Rusal MKPAOIcorium's patented extractive distillation technology is being commercialized via the joint development agreement with Hudson.
